| Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132) |
|---|
| 02/07/2007 | EP1748995A1 Arylsulfonyl benzodioxanes useful for modulation the 5-ht6 receptor, the 5-ht2areceptor or both |
| 02/07/2007 | EP0971748B1 Tetraaza- or n2s2- complexants, and their use in radiodiagnostics or radiotherapy |
| 02/07/2007 | CN1910137A Aryl aniline derivatives as beta2 adrenergic receptor agonists |
| 02/07/2007 | CN1909909A 1-benzyl-5-piperazin-1-yl-3,4-dihydro-1H- quinazolin-2-one derivatives and the respective 1H-benzo(1,2,6)thiadiazine-2,2-dioxide and 1,4-dihydro-benzene as modulators of the 5-hydroxytryptamine recept |
| 02/06/2007 | US7173130 Detection of transmembrane potentials by optical methods |
| 02/06/2007 | US7173128 Benzoxazinone, oxanilide, benzylidene malonate, quinazoline and benzotriazole derivatives; polymer and photographic stabilizers |
| 02/01/2007 | WO2007012964A1 Preparation of alkylpiperazinylphenyl compounds by classical resolution |
| 02/01/2007 | WO2007012580A1 Use of tetrahydrobenzoxazines as stabilisers |
| 02/01/2007 | US20070027148 adrenergic blocking agents such as R-6-Hydroxy-8-{1-hydroxy-2-[2-(4-methoxyphenyl)-1,1-dimethylethylamino]ethyl}-4H-benzo[1,4]oxazin-3-one hydrochloride, used for the treatment of repiratoty system disorders |
| 02/01/2007 | CA2616675A1 Use of tetrahydrobenzoxazines as stabilizers |
| 02/01/2007 | CA2616224A1 10-substituted tetracyclines and methods of use thereof |
| 01/31/2007 | EP1747208A1 Novel sustained-action bronchodilating agents for use in the treatment of respiratory diseases |
| 01/31/2007 | EP1747207A1 Fluorescent method and compounds to monitor protein-lipid binding |
| 01/31/2007 | EP1747196A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 01/31/2007 | CN1906180A New long acting beta-2-agonists and their use as medicaments |
| 01/30/2007 | US7169951 Quinazoline derivatives and pharmaceutical applications thereof |
| 01/30/2007 | US7169776 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 01/30/2007 | CA2228939C Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same |
| 01/25/2007 | WO2007011292A1 N-benzyl-morpholine derivatives as modulators of the chemokine receptor |
| 01/25/2007 | WO2007011065A2 Intermediate compound for synthesizing pharmaceutical agent and production method thereof |
| 01/25/2007 | US20070021394 2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic ester derivative |
| 01/25/2007 | CA2615515A1 Intermediate compound for synthesizing pharmaceutical agent and production method thereof |
| 01/24/2007 | EP1745029A1 Substituted morpholine compounds for the treatment of central nervous system disorders |
| 01/24/2007 | EP1745019A1 Novel compounds of proline and morpholine derivatives |
| 01/24/2007 | EP1744754A1 Morpholine compounds |
| 01/24/2007 | EP0968206B8 N-heterocyclic derivatives as nos inhibitors |
| 01/24/2007 | CN1902183A New process for preparing an optically pure 2-morphinol derivative |
| 01/24/2007 | CN1901971A Cyclopropane compounds and pharmaceutical use thereof |
| 01/24/2007 | CN1900068A Benzoxazine resin intermediate, resin and solidified matter and their preparing method and use |
| 01/24/2007 | CN1900067A Tricyclic compounds, their production and use |
| 01/23/2007 | US7166601 A phenylamide derivatives for treating gastrointestinal reflux disorders, eating disorder obesity and irritable bowel disorder |
| 01/23/2007 | US7166600 Resistant to metabolism, improved half-life and/or clearance properties compared to corresponding carbamates; e.g N-(2-chlorobenzoyl)-p-(morpholinothiocarbonyloxy)tyrosine; used to treat inflammatory diseases e.g rheumatoid arthritis, asthma, psoriasis, multiple sclerosis, inflammatory bowel disease |
| 01/23/2007 | US7166592 Antiinflammatory agents |
| 01/18/2007 | US20070015918 Derivatives of 1,3-diones having a herbicidal activity |
| 01/18/2007 | US20070015762 NPY Y5 antagonist |
| 01/18/2007 | US20070015755 Novel compounds and compositions as protease inhibitors |
| 01/18/2007 | DE102005029093A1 Verfahren zur kontinuierlichen Herstellung eines Amins Process for the continuous preparation of an amine |
| 01/17/2007 | EP1742927A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof |
| 01/17/2007 | EP1482925B1 5-(2-hydroxy-3-'1-(3-trifluoromethylphenyl)-cyclopropl]-propionylamino)-phtalide and related compounds with progesterone receptor modulating activity for use in fertility control and hormone replacement therapy |
| 01/17/2007 | CN1897941A Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity |
| 01/17/2007 | CN1295221C Substituted heterocyclic compounds |
| 01/16/2007 | US7164017 Exhibit electrophysiological activity |
| 01/11/2007 | WO2007005785A1 Thiazoles derivatives as ampk activator |
| 01/11/2007 | WO2007003965A1 Substituted cyclohexyl derivatives as nk-3 receptor antagonists |
| 01/11/2007 | WO2006088720A3 9-substituted tetracyclines |
| 01/11/2007 | WO2005105776A8 Arylsulfonyl benzodioxanes useful for modulation the 5-ht6 receptor, the 5-ht2areceptor or both |
| 01/11/2007 | US20070010517 Pharmaceutical salts of reboxetine |
| 01/11/2007 | US20070010514 Non-steroidal progesterone receptor modulators |
| 01/11/2007 | US20070010513 1-(1-Heteroarylmethyl)piperidin-4-ylcarbonyl)-4-substituted-piperidine derivatives; respiratory allergies, congestion, obesity, metabolic syndrome nonalcoholic fatty liver disease, hepatic steatosis, nonalcoholic steatohepatitis, cirrhosis, hepatacellular carcinoma or cognition deficit disorders |
| 01/11/2007 | US20070010489 Saquinavir-like, a Lopinavir-like, a Ritonavir-like, a Indinavir-lik, a atazanavir-like, Nelfinavir-like.a Tipranavir-like, a Amprenavir-like, a KNI-like. a cyclic carbonyl-like phosphonate HIV protease inhibitors; drug designing |
| 01/11/2007 | US20070010422 Improved bioavailability; for oral and intracolonic administration |
| 01/11/2007 | DE102005030292A1 Nichtsteroidale Progesteronrezeptor-Modulatoren Non-steroidal progesterone receptor modulators |
| 01/11/2007 | CA2614098A1 Thiazoles derivatives as ampk activator |
| 01/11/2007 | CA2611867A1 Substituted cyclohexyl derivatives as nk-3 receptor antagonists |
| 01/10/2007 | EP1741428A2 Cell adhesion inhibitors |
| 01/10/2007 | EP1740557A1 Urea derivatives as antagonists of the vanilloid receptor (vr1) |
| 01/10/2007 | EP1740553A1 Aryl glycinamide derivatives and their use as nk1 antagonists and serotonin reuptake inhibithors |
| 01/10/2007 | CN1894223A Process for the production of DTPA-bis anhydride |
| 01/09/2007 | US7161001 Method for making acylamides by synthesizing and acylating benzoxazines |
| 01/09/2007 | US7160936 P-Bis(4-(oxo)-4H-3,1-benzazin-2-yl)benzene by imino-esterification of isatoic anhydride and terephthaloyl chloride in solvent and alkalie; heat resistance, storage stability, radiation transparent, films, moldings |
| 01/09/2007 | US7160907 Pleuromutilin derivatives |
| 01/09/2007 | US7160882 Long acting β-2-agonists and their use as medicaments |
| 01/09/2007 | CA2102780C Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase |
| 01/04/2007 | WO2007000628A1 Intermediate of amorolfine or its salt |
| 01/04/2007 | WO2006085978A3 Conjugates of a cephalosporin derivative and a fluorophor precursor and related compounds as substrates for beta-lactamase gene expression |
| 01/04/2007 | WO2006047479A3 C-fms kinase inhibitors |
| 01/04/2007 | WO2006010142A3 Mineralocorticoid receptor modulator compounds, processes for their preparation, and their use |
| 01/04/2007 | US20070004726 4-[2-(3-tert-Butyl-4-diethylaminophenyl)-2-hydroxyiminoethoxy]benzoic acid; modulates nuclear retinoic acid receptors; suited for formulation into pharmaceutical compositions useful in human or veterinary medicine, or into cosmetic compositions |
| 01/04/2007 | US20070004716 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient |
| 01/03/2007 | CN1890227A Benzoxazine derivatives and uses thereof |
| 01/03/2007 | CN1887879A Prepn of (2RS, 3RS)-2-[2-(2-ethoxyl phenoxy) benzyl] morpholine |
| 01/03/2007 | CN1293077C Process for preparing 5-[[2(R)-[1(R)-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(S)-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one |
| 01/03/2007 | CN1293063C Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 01/03/2007 | CN1293042C Aromatic amino acid derivates and medicinal compositions |
| 01/02/2007 | US7157457 Compounds useful in the treatment of inflammatory diseases |
| 12/28/2006 | WO2006136461A2 Non-steroidal progesterone receptor modulators |
| 12/28/2006 | WO2006136073A1 Herbicidal n-carboxyl substituted benzoxazine compounds |
| 12/28/2006 | WO2006050054A3 Compounds and methods of use thereof |
| 12/28/2006 | WO2005104711A3 Purification of progesterone receptor modulators |
| 12/28/2006 | CA2611897A1 Non-steroidal progesterone receptor modulators |
| 12/27/2006 | EP1021410B1 Prostaglandin agonists and their use to treat bone disorders |
| 12/27/2006 | CN1886421A Hemiasterlin derivatives and uses thereof |
| 12/27/2006 | CN1886387A Carbon-carbon cross coupling catalyzed by transition metals on solid supports |
| 12/27/2006 | CN1884267A N-carboxylic acid derivative substituted benzooxazine compounds with herbicidal activity |
| 12/26/2006 | US7153963 Phenylalanine derivatives |
| 12/26/2006 | US7153862 αv integrin receptor antagonists |
| 12/26/2006 | US7153852 Skin disorders; antiinflammatory agents; brain disorders; chronic obstructive pulmonary disease; antiarthritic agents; inflammatory bowel disorders |
| 12/21/2006 | WO2006134955A1 1, 2-di(cyclic group)substituted benzene derivative |
| 12/21/2006 | US20060287524 Nile red luminescent compound emitting red light, process for producing the same and luminescence element utilizing the same |
| 12/21/2006 | US20060287293 1-(4-{ethyl-[2-(4-methanesulfonylphenyl)-1-methylethyl]amino}butyl)-4-methanesulfonyl-[1,4]diazepan-2-one; repiratory system disorders: asthma and chronic obstructive pulmonary disease; nervous system, muscular,urogenital, gastrointestinal disorders; antiallergens; side effect reduction |
| 12/21/2006 | US20060286626 Selective chromophores |
| 12/21/2006 | CA2607054A1 1, 2-di(cyclic group)substituted benzene derivative |
| 12/20/2006 | EP1732908A1 Methods and intermediates for the synthesis of delta-9 tetrahydrocannabinol |
| 12/20/2006 | EP1732887A1 1-(1h-indol-1-yl)-3-(4-methylpiperazin-1-yl)-1-phenyl propan-2-ol derivatives and related compounds as modulators of the norepinephrine (ne) and the serotonine (5-ht) activity and the monoamine reuptake for the treatment of vasomotor symptoms (vms) |
| 12/20/2006 | EP1732541A2 Cyclic compounds |
| 12/20/2006 | EP1631557B1 Cyclic hydroxylamine as psychoactive compounds |
| 12/20/2006 | CN1882554A Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient |
| 12/20/2006 | CN1882548A pH sensitive prodrugs of 2,6-diisopropylphenol |
| 12/20/2006 | CN1290829C Process of preparing cyclic thioacid amide compound |
| 12/14/2006 | WO2006116498A3 Purified form of tanaproget |